113 related articles for article (PubMed ID: 26796884)
1. Novel regulators and molecular mechanisms of p53R2 and its disease relevance.
Cho EC; Yen Y
Biochimie; 2016 Apr; 123():81-4. PubMed ID: 26796884
[TBL] [Abstract][Full Text] [Related]
2. The roles of p53R2 in cancer progression based on the new function of mutant p53 and cytoplasmic p21.
Yousefi B; Rahmati M; Ahmadi Y
Life Sci; 2014 Mar; 99(1-2):14-7. PubMed ID: 24486301
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of the p53R2 ribonucleotide reductase subunit by nitric oxide.
Guittet O; Tebbi A; Cottet MH; Vésin F; Lepoivre M
Nitric Oxide; 2008 Sep; 19(2):84-94. PubMed ID: 18474260
[TBL] [Abstract][Full Text] [Related]
4. Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion.
Bourdon A; Minai L; Serre V; Jais JP; Sarzi E; Aubert S; Chrétien D; de Lonlay P; Paquis-Flucklinger V; Arakawa H; Nakamura Y; Munnich A; Rötig A
Nat Genet; 2007 Jun; 39(6):776-80. PubMed ID: 17486094
[TBL] [Abstract][Full Text] [Related]
5. A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage.
Tanaka H; Arakawa H; Yamaguchi T; Shiraishi K; Fukuda S; Matsui K; Takei Y; Nakamura Y
Nature; 2000 Mar; 404(6773):42-9. PubMed ID: 10716435
[TBL] [Abstract][Full Text] [Related]
6. The human ribonucleotide reductase subunit hRRM2 complements p53R2 in response to UV-induced DNA repair in cells with mutant p53.
Zhou B; Liu X; Mo X; Xue L; Darwish D; Qiu W; Shih J; Hwu EB; Luh F; Yen Y
Cancer Res; 2003 Oct; 63(20):6583-94. PubMed ID: 14583450
[TBL] [Abstract][Full Text] [Related]
7. Disruption of the p53-p53r2 DNA repair system in ulcerative colitis contributes to colon tumorigenesis.
Yoshida T; Haga S; Numata Y; Yamashita K; Mikami T; Ogawa T; Ohkusa T; Okayasu I
Int J Cancer; 2006 Mar; 118(6):1395-403. PubMed ID: 16206288
[TBL] [Abstract][Full Text] [Related]
8. Expression and mutation analyses of P53R2, a newly identified p53 target for DNA repair in human gastric carcinoma.
Byun DS; Chae KS; Ryu BK; Lee MG; Chi SG
Int J Cancer; 2002 Apr; 98(5):718-23. PubMed ID: 11920641
[TBL] [Abstract][Full Text] [Related]
9. p53-inducible ribonucleotide reductase (p53R2/RRM2B) is a DNA hypomethylation-independent decitabine gene target that correlates with clinical response in myelodysplastic syndrome/acute myelogenous leukemia.
Link PA; Baer MR; James SR; Jones DA; Karpf AR
Cancer Res; 2008 Nov; 68(22):9358-66. PubMed ID: 19010910
[TBL] [Abstract][Full Text] [Related]
10. Enzymatic property analysis of p53R2 subunit of human ribonucleotide reductase.
Yen Y; Chu B; Yen C; Shih J; Zhou B
Adv Enzyme Regul; 2006; 46():235-47. PubMed ID: 16846634
[No Abstract] [Full Text] [Related]
11. Ribonucleotide reductase subunit p53R2 regulates mitochondria homeostasis and function in KB and PC-3 cancer cells.
Wang X; Liu X; Xue L; Zhang K; Kuo ML; Hu S; Zhou B; Ann D; Zhang S; Yen Y
Biochem Biophys Res Commun; 2011 Jun; 410(1):102-7. PubMed ID: 21640705
[TBL] [Abstract][Full Text] [Related]
12. P53R2, p53 inducible ribonucleotide reductase gene, correlated with tumor progression of non-small cell lung cancer.
Uramoto H; Sugio K; Oyama T; Hanagiri T; Yasumoto K
Anticancer Res; 2006; 26(2A):983-8. PubMed ID: 16619496
[TBL] [Abstract][Full Text] [Related]
13. p53R2-dependent pathway for DNA synthesis in a p53-regulated cell cycle checkpoint.
Yamaguchi T; Matsuda K; Sagiya Y; Iwadate M; Fujino MA; Nakamura Y; Arakawa H
Cancer Res; 2001 Nov; 61(22):8256-62. PubMed ID: 11719458
[TBL] [Abstract][Full Text] [Related]
14. Ribonucleotide reductase subunits M2 and p53R2 are potential biomarkers for metastasis of colon cancer.
Liu X; Zhou B; Xue L; Yen F; Chu P; Un F; Yen Y
Clin Colorectal Cancer; 2007 Jan; 6(5):374-81. PubMed ID: 17311703
[TBL] [Abstract][Full Text] [Related]
15. Akt and p53R2, partners that dictate the progression and invasiveness of cancer.
Yousefi B; Samadi N; Ahmadi Y
DNA Repair (Amst); 2014 Oct; 22():24-9. PubMed ID: 25086499
[TBL] [Abstract][Full Text] [Related]
16. Infrequent alteration in the p53R2 gene in human transitional cell carcinoma of the urinary tract.
Hayashi H; Furihata M; Kuwahara M; Kagawa S; Shuin T; Ohtsuki Y
Pathobiology; 2004; 71(2):103-6. PubMed ID: 14707445
[TBL] [Abstract][Full Text] [Related]
17. p53R2 regulates thioredoxin reductase activity through interaction with TrxR2.
Park SJ; Kim HB; Piao C; Kang MY; Park SG; Kim SW; Lee JH
Biochem Biophys Res Commun; 2017 Jan; 482(4):706-712. PubMed ID: 27866984
[TBL] [Abstract][Full Text] [Related]
18. [p53R2 : DNA repair or mitochondrial DNA synthesis?].
Bourdon A; Rötig A
Med Sci (Paris); 2007 Oct; 23(10):803-5. PubMed ID: 17937886
[No Abstract] [Full Text] [Related]
19. Ribonucleotide reductase small subunit p53R2 suppresses MEK-ERK activity by binding to ERK kinase 2.
Piao C; Jin M; Kim HB; Lee SM; Amatya PN; Hyun JW; Chang IY; You HJ
Oncogene; 2009 May; 28(21):2173-84. PubMed ID: 19398949
[TBL] [Abstract][Full Text] [Related]
20. Ribonucleotide reductase small subunit p53R2 facilitates p21 induction of G1 arrest under UV irradiation.
Xue L; Zhou B; Liu X; Heung Y; Chau J; Chu E; Li S; Jiang C; Un F; Yen Y
Cancer Res; 2007 Jan; 67(1):16-21. PubMed ID: 17210678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]